Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.4M Sell
3,879
-631
-14% -$216K 0.31% 68
2026
Q1
$1.59M Buy
4,510
+144
+3% +$51.3K 0.39% 55
2025
Q4
$1.43M Buy
4,366
+582
+15% +$185K 0.36% 67
2025
Q3
$1.07M Buy
3,784
+32
+0.9% +$9.28K 0.26% 82
2025
Q2
$1.05M Sell
3,752
-985
-21% -$279K 0.27% 83
2025
Q1
$1.48M Sell
4,737
-54
-1% -$15.9K 0.42% 65
2024
Q4
$1.25M Buy
+4,791
New +$1.42M 0.35% 76

Other funds holding AMGN

Natural Investments's AMGN Position: Q2 2026 in Review

Natural Investments reduced its Amgen (AMGN) stake by 14% in Q2 2026, selling an estimated $216K and leaving 3,879 shares worth $1.4M. The position accounts for 0.31% of the portfolio, ranked #68.

Natural Investments first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.59M in Q1 2026. 3,143 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Natural Investments held 3,879 shares of Amgen worth $1.4M as of Q2 2026.
  • Natural Investments sold 631 Amgen shares in Q2 2026, an estimated $216K.
  • Amgen made up 0.31% of Natural Investments's portfolio in Q2 2026, its #68 holding.
  • Natural Investments first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • Natural Investments's Amgen position peaked at $1.59M in Q1 2026.
  • 3,143 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Natural Investments's 13F filing for Q2 2026, filed 31 Jul 2026.